Moreover, we performed the fourth model wherein cardiovascular diseases and medication history (MI, stroke, alcohol use, antihypertensive medication, insulin or oral hypoglycemic agent, lipid-lower therapy, and estrogen replacement) were taken into consideration. This evidence concerns the gene INS and stroke disorder.